Berkowitz Noah 4

What Happened
Noah Berkowitz, Chief Medical Officer of Arvinas, reported a sale of 11,108 shares on May 11, 2026 at $9.94 per share, totaling roughly $110,385. The sale was reported on a Form 4 filed May 13, 2026. According to the filing, this was an automatic (non‑discretionary) sale to cover tax withholding associated with the vesting and settlement of one‑half of RSUs granted May 9, 2025.

Key Details

• Transaction date and price: 2026-05-11 — 11,108 shares @ $9.94 each.
• Proceeds: $110,385 (approx).
• Filing date / timeliness: Form 4 filed 2026-05-13 (two days after transaction; appears timely).
• Shares owned after transaction: Not disclosed in the provided filing details.
• Footnote: Sale executed automatically by the issuer to satisfy tax withholding for vested RSUs; not a discretionary trade.
• Transaction type/code: Sale (S).

Context
Automatic sales to cover tax obligations on vested RSUs are common and are considered routine administrative transactions; they do not necessarily reflect the insider’s view on the company’s prospects. Retail investors often weigh purchases more heavily than such withholding sales when assessing insider sentiment.